A 2-year point-prevalence surveillance of healthcare-associated infections and antimicrobial use in Ferrara University Hospital, Italy

BMC Infect Dis. 2020 Jan 23;20(1):75. doi: 10.1186/s12879-020-4791-8.

Abstract

Background: Healthcare-Associated Infections (HAIs) represent one of the leading issues to patient safety as well as a significant economic burden. Similarly, Antimicrobial Use (AMU) and Resistance (AMR) represent a growing threat to global public health and the sustainability of healthcare services.

Methods: A Point Prevalence Survey (PPS) following the 2016 ECDC protocol for HAI prevalence and AMU was conducted at Ferrara University Hospital (FUH). Data were collected by a team of trained independent surveyors in 2016 and 2018. Risk factors independently associated with HAI were assessed by a multivariate logistic regression model.

Results: Of the 1102 patients surveyed, 115 (10.4%) had an active HAI and 487 (44.2%) were on at least 1 systemic antimicrobial agent. Factors independently associated with increased HAI risk were a "Rapidly Fatal" McCabe score (expected fatal outcome within 1 year), presence of medical devices (PVC, CVC, indwelling urinary catheter or mechanically assisted ventilation) and a length of hospital stay of at least 1 week. The most frequent types of HAI were pneumonia, bloodstream infections, and urinary tract infections. Antimicrobial resistance to third-generation cephalosporins was observed in about 60% of Enterobacteriaceae.

Conclusions: The survey reports a high prevalence of HAI and AMU in FUH. Repeated PPSs are useful to control HAIs and AMU in large acute-care hospitals, highlighting the main problematic factors and allowing planning for improvement actions.

Keywords: Antimicrobial stewardship; Cross infection; Drug resistance, bacterial; Iatrogenic disease; Infection control; Point prevalence survey.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Infective Agents / therapeutic use*
  • Bacteremia / drug therapy
  • Bacteremia / epidemiology*
  • Cross Infection / drug therapy
  • Cross Infection / epidemiology*
  • Enterobacteriaceae / isolation & purification*
  • Female
  • Hospitals, University
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Pneumonia / drug therapy
  • Pneumonia / epidemiology*
  • Prevalence
  • Risk Factors
  • Surveys and Questionnaires
  • Urinary Catheters / microbiology
  • Urinary Tract Infections / drug therapy
  • Urinary Tract Infections / epidemiology*
  • Young Adult

Substances

  • Anti-Infective Agents